Spots Global Cancer Trial Database for trastuzumab (9 weeks) + docetaxel + cef + trastuzumab (up to 51 weeks)
Every month we try and update this database with for trastuzumab (9 weeks) + docetaxel + cef + trastuzumab (up to 51 weeks) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Synergism Or Long Duration (SOLD) Study | NCT00593697 | Breast Neoplasm... | trastuzumab (9 ... trastuzumab (9 ... | 18 Years - | Finnish Breast Cancer Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
